SCHEMBL7729067

SCHEMBL7729067

CC(C)(C)OC(=O)NC[C@H](O)C(=O)NC1C[C@@H](C(=O)O)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.38
ACE P12821 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
HTRA1 Q92743 1/20 0.34
EPHX1 P07099 1/20 0.34
AGTR2 P50052 2/20 0.33
CYP2C9 P11712 1/20 0.33
HSD11B1 P28845 1/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
MMP2 P08253 4/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
ANPEP P15144 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7728349 1.00 BTK (0.38) BTKACESMN1; SMN2KMT2AMEN1
SCHEMBL7728341 1.00 BTK (0.38) BTKACESMN1; SMN2KMT2AMEN1
SCHEMBL7727553 1.00 BTK (0.38) BTKACESMN1; SMN2KMT2AMEN1
SCHEMBL7729316 0.90 MMP2 (0.36) EPHX1CYP2C9HSD11B1CYP1A2POLB
SCHEMBL7727758 0.90 MMP2 (0.36) EPHX1CYP2C9HSD11B1CYP1A2POLB
SCHEMBL7727763 0.90 MMP2 (0.36) EPHX1CYP2C9HSD11B1CYP1A2POLB
SCHEMBL25235410 0.82 BTK (0.54) BTKSMN1; SMN2KMT2AGAACYP2C9
SCHEMBL7736016 0.82 BTK (0.54) BTKSMN1; SMN2KMT2AGAACYP2C9
SCHEMBL7722234 0.82 BTK (0.54) BTKSMN1; SMN2KMT2AGAACYP2C9
SCHEMBL7729066 0.82 BTK (0.54) BTKSMN1; SMN2KMT2AGAACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed